Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
Abstract Background Respiratory syncytial virus (RSV) is the number one cause of lower respiratory tract infections in infants. There are still no vaccines or specific antiviral therapies against RSV, mainly due to the inadequate understanding of RSV pathogenesis. Recent data suggest a role for gut...
Main Authors: | Jeffrey N. Harding, David Siefker, Luan Vu, Dahui You, John DeVincenzo, JF. Pierre, Stephania A. Cormier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12866-020-01816-5 |
Similar Items
-
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
by: Diego R. Hijano, et al.
Published: (2019-03-01) -
Respiratory syncytial virus, infants and intensive therapy
by: Ieda Aparecida Correa Bueno, et al. -
Gut, oral, and nasopharyngeal microbiota dynamics in the clinical course of hospitalized infants with respiratory syncytial virus bronchiolitis
by: Sara Roggiani, et al.
Published: (2023-08-01) -
Genotypes and clinical data of respiratory syncytial virus and metapneumovirus in brazilian infants: a new perspective
by: Adriana Gut Lopes Riccetto, et al. -
Comparison of cytokine expression profiles in infants with a rhinovirus induced lower respiratory tract infection with or without wheezing: a comparison with respiratory syncytial virus
by: Da Eun Roh, et al.
Published: (2017-09-01)